Frédéric Frézard Selected Research

Antimony Potassium Tartrate

1/2018	Accelerated Blood Clearance (ABC) Phenomenon Favors the Accumulation of Tartar Emetic in Pegylated Liposomes in BALB/c Mice Liver.
4/2003	Enhanced schistosomicidal efficacy of tartar emetic encapsulated in pegylated liposomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frédéric Frézard Research Topics

Disease

16	Leishmaniasis 06/2021 - 01/2004
13	Visceral Leishmaniasis (Kala Azar) 05/2022 - 06/2006
7	Body Weight (Weight, Body) 01/2020 - 01/2004
6	Cutaneous Leishmaniasis 05/2022 - 01/2004
6	Infections 02/2021 - 04/2006
2	Stroke (Strokes) 10/2019 - 01/2018
2	Ischemic Stroke 10/2019 - 01/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2016 - 12/2011
1	Coinfection 05/2022
1	Dehydration (Water Stress) 02/2021
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Melanoma (Melanoma, Malignant) 02/2016
1	Genetic Translocation (Chromosomal Translocation) 02/2015
1	Aneuploidy (Aneuploid) 02/2015
1	Cardiotoxicity 01/2014
1	Neoplasms (Cancer) 02/2013
1	Drug-Related Side Effects and Adverse Reactions 02/2013
1	Osteosarcoma (Osteogenic Sarcoma) 06/2012
1	Carcinoma (Carcinomatosis) 06/2012
1	Hemolysis 10/2009
1	Parasitic Diseases (Parasitic Disease) 06/2009
1	Tachypnea 07/2008
1	Sialorrhea 07/2008
1	Schistosomiasis mansoni 04/2003

Drug/Important Bio-Agent (IBA)

17	Meglumine AntimoniateIBA 01/2022 - 01/2004
13	Liposomes (Liposome)IBA 05/2022 - 04/2003
11	Pharmaceutical PreparationsIBA 06/2021 - 01/2008
9	AntimonyIBA 01/2020 - 01/2004
3	Amphotericin B (Amphotericin)FDA LinkGeneric 05/2022 - 04/2015
3	liposomal amphotericin B FDA Link 05/2022 - 10/2019
2	VaccinesIBA 08/2020 - 01/2018
2	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 06/2012
2	Antimony Potassium TartrateIBA 01/2018 - 04/2003
2	CarbonIBA 01/2018 - 09/2013
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2014 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 02/2013 - 06/2012
2	betadex (beta-cyclodextrin)IBA 01/2008 - 01/2004
1	Interleukin-10 ReceptorsIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	GoldIBA 01/2020
1	trypanothione reductaseIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Aligeron (AS 2)IBA 01/2020
1	miltefosine (Impavido)IBA 10/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2019
1	Neuroprotective AgentsIBA 01/2018
1	Attenuated VaccinesIBA 01/2018
1	MART-1 AntigenIBA 02/2016
1	Antineoplastic Agents (Antineoplastics)IBA 02/2016
1	Coordination ComplexesIBA 02/2016
1	LigandsIBA 02/2016
1	CholesterolIBA 04/2015
1	Multidrug Resistance-Associated ProteinsIBA 02/2015
1	Propolis (Bee Bread)IBA 02/2014
1	AntioxidantsIBA 01/2014
1	Biological ProductsIBA 02/2013
1	Pentamidine (NebuPent)FDA LinkGeneric 12/2012
1	Peptides (Polypeptides)IBA 06/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2012
1	lapacholIBA 12/2011
1	SugarsIBA 10/2009
1	CarbohydratesIBA 10/2009
1	CyclodextrinsIBA 06/2009
1	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 06/2009
1	GuanineIBA 10/2006
1	Adenine FDA LinkGeneric 10/2006
1	RibonucleosidesIBA 10/2006
1	hydroxide ionIBA 04/2006

Therapy/Procedure

5	Therapeutics 10/2019 - 06/2009
4	Drug Therapy (Chemotherapy) 01/2022 - 05/2011
1	Immunotherapy 01/2022
1	Complementary Therapies (Alternative Medicine) 06/2021
1	Fluid Therapy (Oral Rehydration Therapy) 02/2021
1	Oral Administration 01/2018
1	Injections 07/2008
1	Aftercare (After-Treatment) 07/2008